| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |